IRTC
iRhythm Technologies, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$123.07
−0.29%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 825.3M | 747.1M | 591.8M | 492.7M | 410.9M |
| Cost of Revenue | 235.6M | 219.9M | 184.3M | 160.9M | 129.3M |
| Gross Profit | 589.7M | 527.3M | 407.5M | 331.8M | 281.6M |
| Operating Expenses | |||||
| R&D Expense | 83.3M | 84.6M | 103.8M | 60.2M | 46.6M |
| SG&A Expense | 505.9M | 479.4M | 418.6M | 385.6M | 322.2M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 10.2M | — | 641.0K | 11.1M | 26.6M |
| Total Operating Expenses | 599.4M | 564.1M | 523.0M | 457.0M | 395.4M |
| Cost and Expenses | 835.0M | 783.9M | 707.3M | 617.8M | 524.7M |
| Operating Income (EBIT) | (9.6M) | (36.8M) | (115.5M) | (125.2M) | (113.8M) |
| Non-Operating | |||||
| Interest Income | 20.9M | 21.5M | 21.9M | 6.2M | 2.4M |
| Interest Expense | 13.2M | 13.2M | 12.8M | 3.6M | 4.1M |
| Net Interest Income | 7.7M | 8.4M | 9.1M | 2.5M | (1.8M) |
| Other Non-Op Income/Expense | (3.3M) | (6.8M) | 2.8M | 2.5M | (2.1M) |
| Non-Operating Income (excl Interest) | (9.8M) | (6.4M) | (15.6M) | (6.2M) | (2.0M) |
| EBT (Pre-Tax Income) | (13.0M) | (43.6M) | (112.7M) | (122.7M) | (115.9M) |
| Income Tax Expense | 971.0K | 953.0K | 565.0K | 750.0K | 269.0K |
| Bottom Line | |||||
| Net Income | (13.9M) | (44.6M) | (113.3M) | (123.4M) | (116.2M) |
| Earnings from Cont. Ops | (13.9M) | (44.6M) | (113.3M) | (123.4M) | (116.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (13.9M) | (44.6M) | (113.3M) | (123.4M) | (116.2M) |
| Per Share | |||||
| Basic EPS | ($0.43) | ($1.39) | ($3.63) | ($4.04) | ($3.88) |
| Diluted EPS | ($0.43) | ($1.39) | ($3.63) | ($4.04) | ($3.88) |
| Revenue Per Share | $25.09 | $23.35 | $18.97 | $16.14 | $13.74 |
| Shares | |||||
| Basic Shares Outstanding | 32.9M | 32.0M | 31.2M | 30.5M | 29.9M |
| Diluted Shares Outstanding | 32.9M | 32.0M | 31.2M | 30.5M | 29.9M |
| Profitability Metrics | |||||
| EBITDA | 20.1M | (4.0M) | (74.1M) | (96.9M) | (92.1M) |
| D&A | 19.9M | 26.5M | 25.8M | 22.1M | 19.6M |
| EBIT | 211.0K | (30.4M) | (99.9M) | (119.0M) | (111.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026